The historic rise of Viagra has long been a symbol of pharmaceutical success, however its future within the broader sector now triggers questions about long-term yields . Generic versions are diminishing patent protection , prompting anxieties that supporting companies significantly dependent to Viagra's former standing could be a speculative decis